EUDAW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)0.0% YoY
Profit margin-40.7%
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
-34.8%
Revenue growth YoY
78.9%
Dividend yield
Beta
0.64

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About EUDA Health Holdings Limited

EUDA Health Holdings Limited is a pioneering biotechnology firm dedicated to developing cutting-edge therapies for dermatological and chronic health conditions. With a strong emphasis on scientific innovation and technological integration, EUDA is committed to addressing significant unmet medical needs through its comprehensive pipeline of transformative products. Backed by a seasoned leadership team with extensive industry experience, the company is well-positioned to capitalize on growth opportunities in the rapidly evolving healthcare landscape, ultimately aimed at improving patient…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
60 KAKI BUKIT PLACE, SINGAPORE, SINGAPORE
Fiscal year end
December
Latest quarter
Sep 30, 2025
Shares outstanding$0
52W high$0.18
52W low$0.02

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer